DYNLRB1 and digestive system infectious disorder: As the intranasal administration of BLP-Tir could induce antigen-specific immunity not only to the respiratory mucosa but also to the intestinal mucosa, it is worth further examination of BLP-adjuvanted nasal vaccine systems as an alternative for oral vaccine systems targeting intestinal infections.